Valsartan Tablets
- All
- News
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
China Directs Medical Institutions To Not Use Recalled Huahai-Made Drug
China's health regulator said on Monday all domestic medical institutions must cooperate with authorities and not use the valsartan blood and heart drug made by Zhejiang Huahai Pharmaceutical that could pose cancer risks.
-
Lupin Launches Generic Hypertension Drug in US
Drug maker Lupin has launched its Amlodipine and Valsartan tablets, used for treatment of hypertension, in the US market after getting approval from the US Food and Drug Administration (FDA).
-
Lupin Launches Generic Diovan Tablets in US
Lupin Pharmaceuticals Inc, the US-based subsidiary of the company, has launched its Valsartan tablets in strengths of 40 mg, 80 mg, 160 mg and 320 mg in the US market after getting nod from the US Food and Drug Administration (USFDA), Lupin Ltd said in a statement.
-
High Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of Novartis
The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major
-
China Directs Medical Institutions To Not Use Recalled Huahai-Made Drug
China's health regulator said on Monday all domestic medical institutions must cooperate with authorities and not use the valsartan blood and heart drug made by Zhejiang Huahai Pharmaceutical that could pose cancer risks.
-
Lupin Launches Generic Hypertension Drug in US
Drug maker Lupin has launched its Amlodipine and Valsartan tablets, used for treatment of hypertension, in the US market after getting approval from the US Food and Drug Administration (FDA).
-
Lupin Launches Generic Diovan Tablets in US
Lupin Pharmaceuticals Inc, the US-based subsidiary of the company, has launched its Valsartan tablets in strengths of 40 mg, 80 mg, 160 mg and 320 mg in the US market after getting nod from the US Food and Drug Administration (USFDA), Lupin Ltd said in a statement.
